Table 1. Serum concentrations of MIC-1 and PSA in PCa patients.
PSA | MIC-1 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Number | Mean | Median | Range | 95th percentile | Mean | Median | Range | 95th percentile | |
Normal | 14 | 1.03 | 0.80 | 0.25–2.30 | 2.30 | 0.93 | 0.90 | 0.53–1.33 | 1.33 |
Bx-ve | 14 | 6.42 | 4.80 | 3.80–19.40 | 17.62 | 0.88 | 0.87 | 0.34–1.45 | 1.43 |
PSA <2.5 | 14 | 1.80 | 1.90 | 0.10–2.46 | 2.44 | 1.24 | 1.06 | 0.66–2.16 | 2.14 |
PSA 2.5–10 | 14 | 5.11 | 4.65 | 2.60–9.10 | 9.00 | 1.35 | 1.11 | 0.63–2.76 | 2.62 |
PSA ≥ 10 | 14 | 29.86 | 12.90 | 10.00–241.30 | 196.96 | 1.72 | 1.58 | 1.03–2.70 | 2.68 |
All nonPCa | 28 | 3.72 | 3.05 | 0.25–19.40 | 11.39 | 0.90 | 0.89 | 0.34–1.45 | 1.35 |
All PCa patients | 42 | 12.26 | 4.65 | 0.10–241.30 | 18.58 | 1.44 | 1.24 | 0.63–2.76 | 2.64 |
Concentration units: ng/ml. Bx-ve: biopsy negative.